Sight Sciences, Inc.
Clinical trials sponsored by Sight Sciences, Inc., explained in plain language.
-
Glaucoma pressure fight: new device vs laser – which wins?
Disease control TerminatedThis study tested a new device called VISCO360 against a standard laser treatment (SLT) to lower eye pressure in adults with open-angle glaucoma. The goal was to see which procedure is safer and more effective. The study was stopped early and included 29 people who had already ha…
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Glaucoma device showdown ends early
Disease control TerminatedThis study compared two surgical devices—the OMNI system and the iStent inject—for lowering eye pressure in adults with open-angle glaucoma who already had cataract surgery. The goal was to see which device was safer and more effective. However, the study was stopped early and on…
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Disease control
Last updated May 18, 2026 11:59 UTC
-
New TearCare device aims to soothe dry eyes better than warm compresses
Symptom relief TerminatedThis study tested the TearCare system, a device that applies heat to the eyelids, in 14 people with dry eye disease. The goal was to see if it safely improves tear stability and symptoms better than standard warm compresses and lid massage. The study was terminated early, so resu…
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated May 26, 2026 07:07 UTC